Impact of COVID-19 on Patients with Inflammatory Bowel Disease

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in Wuhan, China, in late 2019. Responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic, SARS-CoV-2 is one of three structurally similar beta-coronaviruses that can cause a strong upregulation of cytoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrose, Paula A., Goodman, Wendy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373928/
https://www.ncbi.nlm.nih.gov/pubmed/35966234
http://dx.doi.org/10.14218/jerp.2021.00014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373928/
https://www.ncbi.nlm.nih.gov/pubmed/35966234
http://dx.doi.org/10.14218/jerp.2021.00014

Ejemplares similares